A recent study in the journal Cancer Research demonstrates that a RIG-I agonist has potent immunogenic and therapeutic effects in breast cancer. http://news.vumc.org/2018/12/13/breast-cancer-killing-rig/#new_tab Fri, 12/14/2018 - 12:00 Breast_Cancer Breast_Cancer_Research_Program Breast_SPORE Immunotherapy
